je.st
news
Biogen Idec's 'Plegridy' therapy for multiple sclerosis delayed by FDA
2014-03-18 19:56:24| Biotech - Topix.net
Two new multiple sclerosis pills have hit the market and a third is on the way to replace shots with potentially serious side effects.
Tags: multiple
therapy
delayed
fda
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||